AI Scribes Reduce Documentation Burden but Deliver Modest Gains in Efficiency, Multisite Study Finds
A longitudinal cohort study explored the clinical efficiency benefits of AI ambient scribe adoption across multiple academic institutions, finding that scribes led to modest reductions in time spent on electronic health records and documentation.
To evaluate the impact of AI-powered medical scribes on clinician workload and productivity metrics across multiple health systems.
Key Findings:
AI scribe adoption led to a statistically significant reduction of 13.4 minutes in total EHR time and 16.0 minutes in documentation time.
Clinicians completed approximately 0.49 additional patient visits per week post-adoption, with significant variations across clinician groups.
Benefits varied by clinician group, with primary care and high-frequency users experiencing the most significant improvements.
Estimated average revenue increase of $167 per clinician per month due to higher visit volume and improved documentation.
Interpretation:
AI scribe adoption is associated with modest reductions in documentation burden and slight increases in productivity, but the benefits are not uniform across all clinician groups, highlighting the need for future research on patient outcomes and health equity.
Limitations:
The study's nonrandomized design may confound results with other unmeasured factors, potentially affecting the validity of the findings.
Limited data on patient experience, health outcomes, and equity.
Conclusion:
While AI scribes can reduce documentation burden and improve productivity, the overall benefits are modest and vary by user. Future research should focus on the impact of AI on patient outcomes and health equity, rather than solely on efficiency metrics.
ASCO AI in Oncology
is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in
ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.